Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Pipeline Review, H1 2016 Featuring Naia, Shire, Tasly Pharmaceutical Group & Zealand Pharma - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) Overview
3. Therapeutics Development
4. Pipeline Products for Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Overview
5. Pipeline Products for Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Comparative Analysis
6. Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Therapeutics under Development by Companies
7. Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Therapeutics under Investigation by Universities/Institutes
8. Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Products under Development by Companies
13. Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Products under Investigation by Universities/Institutes
14. Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Companies Involved in Therapeutics Development

• Naia Limited
• Shire Plc
• Tasly Pharmaceutical Group Co., Ltd.
• Zealand Pharma A/S

For more information visit http://www.researchandmarkets.com/research/llnsbx/glucagonlike